Driehaus Capital Management LLC Adma Biologics, Inc. Transaction History
Driehaus Capital Management LLC
- $9.17 Billion
- Q1 2025
A detailed history of Driehaus Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 2,946,570 shares of ADMA stock, worth $52.7 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
2,946,570
Previous 1,371,207
114.89%
Holding current value
$52.7 Million
Previous $23.5 Million
148.59%
% of portfolio
0.64%
Previous 0.23%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
381Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$333 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$301 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$230 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$205 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$101 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.51B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...